* Dyadic International Inc DYAI.OQ DYAI.O is expected
to show
a rise in quarterly revenue when it reports results on August
9.
* The Jupiter Florida-based company is expected to report
a
97.6% increase in revenue to $1.3 million from $658 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Dyadic
International Inc
is for a loss of 5 cents per share.
* The one available analyst rating on the shares is "buy".
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".
* Wall Street's median 12-month price target for Dyadic
International Inc is $6, above its last closing price
of $1.71.
This summary was machine generated August 8 at 02:04 GMT. All
figures in US dollars unless otherwise stated